Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

60 results about "Bioluminescence imaging" patented technology

Bioluminescence imaging (BLI) is a technology developed over the past decade that allows for the noninvasive study of ongoing biological processes in small laboratory animals. Recently, bioluminescence tomography (BLT) has become possible and several systems have become commercially available. In 2011, PerkinElmer acquired one of the most popular lines of optical imaging systems with bioluminescence from Caliper Life Sciences.

Multimodal silica-based nanoparticles

The present invention provides a fluorescent silica-based nanoparticle that allows for precise detection, characterization, monitoring and treatment of a disease such as cancer. The nanoparticle has a range of diameters including between about 0.1 nm and about 100 nm, between about 0.5 nm and about 50 nm, between about 1 nm and about 25 nm, between about 1 nm and about 15 nm, or between about 1 nm and about 8 nm. The nanoparticle has a fluorescent compound positioned within the nanoparticle, and has greater brightness and fluorescent quantum yield than the free fluorescent compound. The nanoparticle also exhibits high biostability and biocompatibility. To facilitate efficient urinary excretion of the nanoparticle, it may be coated with an organic polymer, such as poly(ethylene glycol) (PEG). The small size of the nanoparticle, the silica base and the organic polymer coating minimizes the toxicity of the nanoparticle when administered in vivo. In order to target a specific cell type, the nanoparticle may further be conjugated to a ligand, which is capable of binding to a cellular component associated with the specific cell type, such as a tumor marker. In one embodiment, a therapeutic agent may be attached to the nanoparticle. To permit the nanoparticle to be detectable by not only optical fluorescence imaging, but also other imaging techniques, such as positron emission tomography (PET), single photon emission computed tomography (SPECT), computerized tomography (CT), bioluminescence imaging, and magnetic resonance imaging (MRI), radionuclides/radiometals or paramagnetic ions may be conjugated to the nanoparticle.
Owner:SLOAN KETTERING INST FOR CANCER RES +1

Symmetrical double-rhodamine B fluorescent probe for detecting mercury ion and preparation method of fluorescent probe

InactiveCN103254893AEnables visualization of fluorescence imagingFluorescent signal enhancementOrganic chemistryFluorescence/phosphorescenceFluorescenceAcyl group
The invention relates to a symmetrical double-rhodamine B fluorescent probe for detecting a mercury ion and a preparation method of the fluorescent probe. The structural formula of the symmetrical double-rhodamine B fluorescent probe RBSRB (rhodamine B-symmetrical-rhodamine B) is as shown in the specification. The preparation method comprises the following steps: adding rhodamine B and phosphorus oxychloride into a solvent for reflux reaction for 20-24h at 85-90 DEG C, obtaining rhodamine B acyl chloride, dissolving rhodamine B acyl chloride and 2-bromine ethylamine in the solvent, stirring for reaction for one night at room temperature, purifying to obtain rhodamine B acyl-2-bromine ethylamine, adding rhodamine B acyl-2-bromine ethylamine and sodium sulfide into the solvent for reflux reaction for 5-8h at 80-85 DEG C, and purifying to obtain the fluorescent probe. The fluorescent probe is symmetrical double-rhodamine B amide connected by a sulphur atom; only alcohol under 1% is introduced as a cosolvent during an experiment; the fluorescent probe is high in selectivity, and has high selectivity to the mercury ion; other common ions do not interfere with the fluorescent probe obviously; and the fluorescent probe has an application prospect in bioluminescence imaging.
Owner:DONGHUA UNIV

Microplastic labeled by long-persistence luminescent nano particles, preparation method and application

InactiveCN108485097AAvoid interferenceAccurate and reliable scientific experiment dataLuminescent compositionsOrganic solventEnvironmental effect
The invention belongs to the technical field of environmental science, and discloses a microplastic labeled by long-persistence luminescent nano particles, a preparation method and application. The method includes the steps that 1, the long-persistence luminescent nano particles are dispersed in organic solvent to obtain long-persistence luminescent nano particles dispersion liquid; 2, plastic macromolecules are dissolved in organic solvent to obtain a plastic macromolecule solution; 3, the long-persistence luminescent nano particles dispersion liquid and the plastic macromolecules solution are evenly mixed to obtain mixed dispersion liquid; 4, under stirring conditions, the mixed dispersion liquid is added into a dispersion medium aqueous solution dropwisely, and after dropwise adding, stirring is continued to obtain dispersion liquid of microplastic particles labeled by the long-persistence luminescent nano particles, or the microplastic particles labeled by the long-persistence luminescent nano particles are separated from the dispersion liquid. The method is simple, the product is stable in structure and good in luminescence performance, no background fluorescence disturbance exists, and the sensitivity is high; the microplastic labeled by the long-persistence luminescent nano particles, the preparation method and the application have potential application values in the fields of environmental effects of microplastics and bioluminescence imaging.
Owner:JINAN UNIVERSITY

Multimodal silica-based nanoparticles

The present invention provides a fluorescent silica-based nanoparticle that allows for precise detection, characterization, monitoring and treatment of a disease such as cancer. The nanoparticle has a range of diameters including between about 0.1 nm and about 100 nm, between about 0.5 nm and about 50 nm, between about 1 nm and about 25 nm, between about 1 nm and about 15 nm, or between about 1 nm and about 8 nm. The nanoparticle has a fluorescent compound positioned within the nanoparticle, and has greater brightness and fluorescent quantum yield than the free fluorescent compound. The nanoparticle also exhibits high biostability and biocompatibility. To facilitate efficient urinary excretion of the nanoparticle, it may be coated with an organic polymer, such as poly(ethylene glycol) (PEG). The small size of the nanoparticle, the silica base and the organic polymer coating minimizes the toxicity of the nanoparticle when administered in vivo. In order to target a specific cell type, the nanoparticle may further be conjugated to a ligand, which is capable of binding to a cellular component associated with the specific cell type, such as a tumor marker. In one embodiment, a therapeutic agent may be attached to the nanoparticle. To permit the nanoparticle to be detectable by not only optical fluorescence imaging, but also other imaging techniques, such as positron emission tomography (PET), single photon emission computed tomography (SPECT), computerized tomography (CT), bioluminescence imaging, and magnetic resonance imaging (MRI), radionuclides / radiometals or paramagnetic ions may be conjugated to the nanoparticle.
Owner:CORNELL UNIVERSITY +2

Method for positioning bioluminescence imaging light sources in small animal

InactiveCN103767686AAchieve positioningImprove light source positioning accuracyDiagnostic recording/measuringSensorsSmall animalMathematical model
The invention discloses a method for positioning bioluminescence imaging light sources in small animal. The method is characterized by comprising the following steps: building a relation between body surface measured data vectors and in-vivo unknown light source distribution of the small animal by utilizing a quantitative optical molecular tomography device and a finite element method; computing the in-vivo light source distribution of the small animal by adopting an algebraic iterative reconstruction method; determining a threshold value according to sparseness, and performing correction on the light source distribution, obtained by adopting the algebraic iterative reconstruction method, by utilizing the threshold value; circulating for multiple times to finally obtain the in-vivo light source distribution of the small animal to realize the positioning of the bioluminescence imaging light sources. The method disclosed by the invention has the beneficial effects that the L0 normalization item does not need to be added to a mathematic model of the reconstruction problem, and approximation analysis does not even to be performed on the L0 norm by adopting the L1 norm and the Lp (0&1t; p≪ 1) norm, but the correction is performed on the light source distribution, obtained by adopting the algebraic iterative reconstruction method, directly by utilizing the sparseness. As norm approximation in the prior art is not adopted, the in-vivo light source positioning precision of the small animal is improved by the method provided by the invention.
Owner:XIDIAN UNIV

Type 2 diabetes mellitus mouse pancreatic cancer model construction method based on living body imaging technology

The invention discloses a type 2 diabetes mellitus mouse pancreatic cancer model construction method based on a living body imaging technology. The method comprises the following steps: culturing human-derived pancreatic cancer tumor cells, and then carrying out cell transfection to construct a pancreatic cancer cell strain capable of stably expressing luciferase genes; establishing a type 2 diabetes mellitus mouse model, then establishing a type 2 diabetes mellitus mouse pancreatic cancer model, finally carrying out living body bioluminescence imaging observation, dynamically observing tumorgrowth and metastasis conditions in a model mouse by using an animal living body imaging system, then placing the model mouse in the living body imaging system for exposure imaging, and collecting photon numerical values of the model mouse; and drawing a growth curve of the tumor cells in the model mouse. The method disclosed by the invention provides an ideal experimental animal model for researching a molecular mechanism from blood glucose regulation of pancreatic cancer to early metastasis in vivo, and opens up a new field for preparing animal models for clinically treating chronic diseasescomplicated with malignant tumors.
Owner:广西医科大学附属武鸣医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products